| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Agricultural Chemistry, Faculty of Agriculture [M. Y., T. B.] and Institute of Applied Microbiology [S. N.], The University of Tokyo, Bunkyo-ku, Tokyo 113, Japan
The fungistatic antibiotics trichostatins (TS) A and C were isolated from culture broth of Streptomyces platensis No. 145 and were found to be potent inducers of differentiation in murine erythroleukemia (Friend and RV133) cells at concentrations of 1.5 x 10-8 M for TSA and 5 x 10-7 M for TSC. Differentiation induced by TS was cooperatively enhanced by UV irradiation but not by treatment with dimethyl sulfoxide. This enhanced activity was completely inhibited by adding cycloheximide to the culture medium 2 h after exposure to TS, suggesting that TS are dimethyl sulfoxide-type inducers of erythroid differentiation. No inhibitory effect of TS was observed on macromolecular synthesis in cultured cells.
1 To whom requests for reprints should be addressed.
Received 10/15/86. Revised 3/20/87. Accepted 4/10/87.
This article has been cited by other articles:
|
|
 |
|
  H. Dombrowsky and S. Uhlig Steroids and histone deacetylase in ventilation-induced gene transcription Eur. Respir. J., November 1, 2007; 30(5): 865 - 877. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tayaramma, B. Ma, M. Rohde, and H. Mayer Chromatin-Remodeling Factors Allow Differentiation of Bone Marrow Cells into Insulin-Producing Cells Stem Cells, December 1, 2006; 24(12): 2858 - 2867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Sanderson, G. W. Taylor, E. O. Aboagye, J. P. Alao, J. R. Latigo, R. C. Coombes, and D. M. Vigushin PLASMA PHARMACOKINETICS AND METABOLISM OF THE HISTONE DEACETYLASE INHIBITOR TRICHOSTATIN A AFTER INTRAPERITONEAL ADMINISTRATION TO MICE Drug Metab. Dispos., October 1, 2004; 32(10): 1132 - 1138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ju and M. T. Muller Histone Deacetylase Inhibitors Activate p21WAF1 Expression via ATM Cancer Res., June 1, 2003; 63(11): 2891 - 2897. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Md. M. Rahman, A. Kukita, T. Kukita, T. Shobuike, T. Nakamura, and O. Kohashi Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages Blood, May 1, 2003; 101(9): 3451 - 3459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Witt, S. Monkemeyer, G. Ronndahl, B. Erdlenbruch, D. Reinhardt, K. Kanbach, and A. Pekrun Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin Blood, March 1, 2003; 101(5): 2001 - 2007. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kamitani, S. Taniura, K. Watanabe, M. Sakamoto, T. Watanabe, and T. Eling Histone acetylation may suppress human glioma cell proliferation when p21WAF/Cip1 and gelsolin are induced Neuro-oncol, April 1, 2002; 4(2): 95 - 101. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Duharcourt and M.-C. Yao Role of Histone Deacetylation in Developmentally Programmed DNA Rearrangements in Tetrahymena thermophila Eukaryot. Cell, April 1, 2002; 1(2): 293 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. M. Richon and J. P. O'Brien Histone Deacetylase Inhibitors: A New Class of Potential Therapeutic Agents for Cancer Treatment : Commentary re: V. Sandor et al., Phase I Trial of the Histone Deacetylase Inhibitor, Depsipeptide (FR901228, NSC 630176), in Patients with Refractory Neoplasms. Clin. Cancer Res., 8: 718-728, 2002. Clin. Cancer Res., March 1, 2002; 8(3): 662 - 664. [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Wu, S. Y. Archer, B. Hinnebusch, S. Meng, and R. A. Hodin Transient vs. prolonged histone hyperacetylation: effects on colon cancer cell growth, differentiation, and apoptosis Am J Physiol Gastrointest Liver Physiol, March 1, 2001; 280(3): G482 - G490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A Johnson Chromatin modification and disease J. Med. Genet., December 1, 2000; 37(12): 905 - 915. [Full Text]
|
|
|
|
 |
|
 S Siavoshian, J-P Segain, M Kornprobst, C Bonnet, C Cherbut, J-P Galmiche, and H M Blottiere Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression Gut, April 1, 2000; 46(4): 507 - 514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Huang and S. J. Brandt mSin3A Regulates Murine Erythroleukemia Cell Differentiation through Association with the TAL1 (or SCL) Transcription Factor Mol. Cell. Biol., March 15, 2000; 20(6): 2248 - 2259. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. C. Sambucetti, D. D. Fischer, S. Zabludoff, P. O. Kwon, H. Chamberlin, N. Trogani, H. Xu, and D. Cohen Histone Deacetylase Inhibition Selectively Alters the Activity and Expression of Cell Cycle Proteins Leading to Specific Chromatin Acetylation and Antiproliferative Effects J. Biol. Chem., December 3, 1999; 274(49): 34940 - 34947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Glick, S. L. Swendeman, D. C. Coffey, R. A. Rifkind, P. A. Marks, V. M. Richon, and M. P. La Quaglia Hybrid Polar Histone Deacetylase Inhibitor Induces Apoptosis and CD95/CD95 Ligand Expression in Human Neuroblastoma Cancer Res., September 1, 1999; 59(17): 4392 - 4399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Redner, J. Wang, and J. M. Liu Chromatin Remodeling and Leukemia: New Therapeutic Paradigms Blood, July 15, 1999; 94(2): 417 - 428. [Full Text] [PDF]
|
|
|
|
|
|
Y.-Q. Feng, R. Alami, and E. E. Bouhassira Enhancer-Dependent Transcriptional Oscillations in Mouse Erythroleukemia Cells Mol. Cell. Biol., July 1, 1999; 19(7): 4907 - 4917. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Huang, C. P. Reed, J.-S. Zhang, V. Shridhar, L. Wang, and D. I. Smith Carboxypeptidase A3 (CPA3): A Novel Gene Highly Induced by Histone Deacetylase Inhibitors during Differentiation of Prostate Epithelial Cancer Cells Cancer Res., June 1, 1999; 59(12): 2981 - 2988. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Zhang and J. J. Bieker Acetylation and modulation of erythroid Kruppel-like factor (EKLF) activity by interaction with histone acetyltransferases PNAS, August 18, 1998; 95(17): 9855 - 9860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Y. Archer, S. Meng, A. Shei, and R. A. Hodin p21WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells PNAS, June 9, 1998; 95(12): 6791 - 6796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. Richon, S. Emiliani, E. Verdin, Y. Webb, R. Breslow, R. A. Rifkind, and P. A. Marks A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases PNAS, March 17, 1998; 95(6): 3003 - 3007. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
